SPOTLIGHT -
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
With MDMA on Hold, What’s Next for Psychedelics?
Blue Light Blockers: A Behavior Therapy for Mania
New Study Initiated to Evaluate Use of Deep Brain Stimulation for Treatment-Resistant Depression
Blue Light, Depression, and Bipolar Disorder
Major Depressive Disorder Research Roundup: August 29, 2024
Depression With Anhedonia vs Dysthymia: Do We Understand the Difference?